Catherine S Perry

Pathology

Phone(520) 626-1271
Emailcspier@email.arizona.edu

5400 Citations
35 h-Index

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Catherine S Perry is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

4 Similar Profiles

Non-Hodgkin's Lymphoma Medicine & Life Sciences

Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences

Lymphoma Medicine & Life Sciences

Peripheral T-Cell Lymphoma Medicine & Life Sciences

B-Cell Lymphoma Medicine & Life Sciences

Phenotype Medicine & Life Sciences

B-Lymphocytes Medicine & Life Sciences

Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2018

5400 Citations
35 h-Index
80 Article
1 Letter

18 Citations (Scopus)

Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus 131I-Tositumomab: Long-Term follow-up of phase III randomized study SWOG-S0016

Shadman, M., Li, H., Rimsza, L. M., Leonard, J. P., Kaminski, M. S., Braziel, R. M., Perry, C. S., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S., LeBlanc, M., Smith, S. M., Fisher, R. I., Friedberg, J. W. & Press, O. W., Mar 1 2018, In : Journal of Clinical Oncology. 36, 7, p. 697-703 7 p.

Research output: Contribution to journal › Article

Follicular Lymphoma

Therapeutics

Second Primary Neoplasms

Myelodysplastic Syndromes

Acute Myeloid Leukemia

3 Citations (Scopus)

Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

Rimsza, L. M., Li, H., Braziel, R. M., Perry, C. S., Persky, D. O., Dunlap, J., Leblanc, M., Bartlett, N., Leonard, J. P., Smith, S. M., Press, O. W. & Friedberg, J. W., Mar 23 2018, In : Haematologica. 103, 4, p. e151-e153

Research output: Contribution to journal › Letter

Follicular Lymphoma

3 Citations (Scopus)

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Kelly, K. R., Friedberg, J. W., Park, S. I., McDonagh, K., Hayslip, J., Persky, D., Ruan, J., Puvvada, S. D., Rosen, P., Iyer, S. P., Stefanovic, A., Bernstein, S. H., Weitman, S., Karnad, A., Monohan, G., VanderWalde, A., Mena, R., Schmelz, M., Perry, C. S., Groshen, S. & 5 others, Venkatakrishnan, K., Zhou, X., Sheldon-Waniga, E., Jane Leonard, E. & Mahadevan, D., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6150-6159 10 p.

Research output: Contribution to journal › Article

Aurora Kinase A

Vincristine

B-Cell Lymphoma

Non-Hodgkin's Lymphoma

Lymphoma, Large B-Cell, Diffuse

5 Citations (Scopus)

Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: A novel therapeutic strategy

Islam, S., Vick, E., Huber, B., Morales, C., Perry, C. S., Cooke, L., Weterings, E. . & Mahadevan, D., Jan 1 2017, In : Oncotarget. 8, 59, p. 100326-100338 13 p.

Research output: Contribution to journal › Article

Aurora Kinases

Peripheral T-Cell Lymphoma

Phosphatidylinositol 3-Kinases

Non-Hodgkin's Lymphoma

Vincristine

10 Citations (Scopus)

Disruption of aneuploidy and senescence induced by aurora inhibition promotes intrinsic apoptosis in double hit or double expressor diffuse large B-cell lymphomas

Islam, S., Qi, W., Morales, C., Cooke, L., Perry, C. S., Weterings, E. . & Mahadevan, D., Oct 1 2017, In : Molecular Cancer Therapeutics. 16, 10, p. 2083-2093 11 p.

Research output: Contribution to journal › Article

Lymphoma, Large B-Cell, Diffuse

Aneuploidy

Apoptosis

Aurora Kinases

Cell Death